PATENTS related term(s) Copyrights

Bills and resolutions

California: withdraw certain Federal land in San Bernardino National Forest from location, entry, and patent under mining laws (see H.R. 6869), H6997 [19DE]

China: prohibit certain Communist Party members from entering U.S. until government ceases theft of U.S. intellectual property (see H.R. 1016), H838 [14FE]

Crime: allow owner of trade secret redress of theft of trade secrets extraterritorially (see H.R. 844), H709 [6FE]

Dept. of Commerce: provide for presumption of denial of licenses for export, reexport, or in-country transfer of technology to end users in China or Russia (see S. 2170), S2223 [22JN]

Dept. of HHS: conduct study on designation of biosimilar biological products as interchangeable (see S. 1522), S1602 [10MY]

Dept. of the Interior: eliminate patenting of Federal lands, impose Federal minerals royalty, establish fund for cleanup of abandoned mines, and review certain lands to determine availability for future mining (see S. 1742), S1745 [18MY] (see H.R. 3495), H2453 [18MY]

Depts. of Homeland Security and State: require aliens applying for certain visas to disclose if they receive funds from China or Chinese Communist Party (see H.R. 688), H576 [31JA]

Double patenting: prevent (see H.R. 6436), H5892 [15NO]

Drugs: require sponsors of drug applications and holders of approved applications to provide certain submissions and communications to FDA and Patent and Trademark Office (see S. 2780), S4440 [13SE] (see H.R. 5429), H4296 [13SE]

Economy: strengthen patent system and combat abuse (see S. 2220), S2287 [10JY]

FAA: prohibit airport improvement grants funds from being used for contracts with entities that have violated intellectual property rights of U.S. entities (see S. 1965), S2096 [14JN]

FDA: establish special rules allowing generic manufacturers to sue brand-name manufacturers who overstate applications concerning method of use patents (see S. 1128), S1090 [30MR]

FTC: prohibit anticompetitive use of patents, known as product hopping, by drug product manufacturers (see S. 150), S147 [30JA]

GAO: require report on disclosure process for intellectual property created under Federal grant (see H.R. 6684), H6740 [7DE]

Intergovernmental relations: establish interagency task force between Patent and Trademark Office and FDA for sharing information and providing technical assistance relative to patents (see S. 79), S98 [25JA] (see H.R. 1717), H1326 [22MR]

ITC: protect domestic industries from abusive patent litigation (see H.R. 3535), H2455 [18MY]

Motor vehicles: provide for exception from infringement for certain component parts (see H.R. 1707), H1326 [22MR]

Patent and Trademark Office: address matters relative to patent subject matter eligibility (see S. 2140), S2222 [22JN]

——— reform Patent Trial and Appeal Board to encourage and protect property rights of inventors and maintain U.S. as leading innovation economy (see H.R. 4370), H3149 [27JN]

——— require disclosures in patent applications on ties to China and other foreign adversaries (see H.R. 5475), H4344 [14SE]

Pharmaceuticals: improve actions available to eligible product developers in event of delays in receiving covered product for purposes of generic drug or biosimilar biological product development (see S. 1120), S1090 [30MR]

——— prohibit prescription drug manufacturers from compensating other companies to delay entry of generic drugs, biosimilar biological products, or interchangeable biological products into market (see S. 142), S147 [30JA] (see H.R. 6275), H5544 [7NO]

——— prohibit use of patents, trade secrets, or other intellectual property to inhibit competition (see S. 574), S567 [1MR] (see H.R. 4692), H3640 [17JY]

Prioritizing Resources and Organization for Intellectual Property Act: authorize Intellectual Property Protection Legal Aid program to assist small businesses to protect intellectual property (see S. 2566), S3753 [27JY]

SBA: improve commercialization activities in Small Business Innovation Research Program and Small Business Technology Transfer Program (see S. 1396), S1463 [2MY] (see H.R. 3056), H2125 [2MY]

Lists

National Academy of Inventors, Inc., Fellows Program inductees, E578 [16JN]

Remarks in House

Colleges and universities: address influence of China in institutions of higher education, H1751–H1755 [17AP]

National Academy of Inventors, Inc.: tribute to Fellows Program inductees, E578 [16JN]

Remarks in Senate

Pharmaceuticals: prohibit prescription drug manufacturers from compensating other companies to delay entry of generic drugs, biosimilar biological products, or interchangeable biological products into market (S. 142), S218 [2FE]

Reports filed

Affordable Prescriptions for Patients Act: Committee on the Judiciary (Senate) (S. 150), S567 [1MR]

Interagency Patent Coordination and Improvement Act: Committee on the Judiciary (Senate) (S. 79), S567 [1MR]

Preserve Access to Affordable Generics and Biosimilars Act: Committee on the Judiciary (Senate) (S. 142), S567 [1MR]

Research Advancing to Market Production for Innovators Act: Committee on Small Business and Entrepreneurship (Senate) (S. 1396), S3521 [25JY]

Texts of

S. 79, Interagency Patent Coordination and Improvement Act, S102 [25JA]